Introduction
Dental practice is ideally meant to be guided by solid scientific evidence, yet the reality is that the evidence base in dentistry has long been perceived as weaker and more fragmented compared to other health fields like medicine. Oral diseases affect billions worldwide, making oral health a critical public health issue. However, persistent shortcomings in dental research – from an over-reliance on laboratory studies and small clinical trials to slow adoption of new findings – have hindered our ability to translate science into practice. The result is a profession where clinical decisions often rely on tradition or intuition (“what works in my hands”) rather than high-quality evidence, with wide variations in care and outcomes. This research journal article will delve into the multifaceted weaknesses in dental research that underlie this evidence gap. We will examine how methodological issues, funding and industry influences, disciplinary silos, and cultural factors contribute to inconsistent and low-confidence evidence in dentistry. We will also explore the consequences for patient care – including contradictory guidelines and variable treatment quality – and discuss emerging efforts and recommendations to strengthen the dental evidence base. By learning from these shortcomings, the dental community can move toward more robust, interdisciplinary, and patient-centered research that truly informs and improves clinical practice.
Heavy Reliance on Laboratory Studies vs. Clinical Evidence
One fundamental weakness in dental research is the heavy reliance on benchtop in vitro studies in lieu of extensive clinical trials. Laboratory experiments are appealing because they can be executed quickly and repeatedly, allowing researchers to publish findings on new materials or techniques in a short time. Many dental materials – such as composite resins, bonding agents, and 3D-printed prosthetic materials – are often first tested under idealized lab conditions for properties like bond strength or wear resistance. While these in vitro studies are valuable for screening and initial comparisons, they are a poor representation of real-world clinical outcomes. The oral environment is complex: materials in the mouth are bathed in saliva, challenged by bacterial biofilms, and subjected to continuous mechanical forces and thermal changes. These conditions lead to degradation of dental materials over time, which short-term lab tests often cannot simulate fully. Consequently, a new material might perform brilliantly in a laboratory ranking, only to fail or degrade much faster under actual clinical use. This bench-to-bedside disconnect is widely acknowledged – laboratory tests frequently do not correlate well with clinical performance. As one review noted, there is a “general lack of data that correlates clinical performance with laboratory materials testing.” In other words, in vitro evidence is often a poor predictor of real-world effectiveness, especially without follow-up by long-term clinical trials.
The heavy emphasis on laboratory research is partly a consequence of convenience and cost. Bench studies can be completed in weeks or months, whereas robust clinical trials in dentistry typically require years of follow-up to observe meaningful outcomes (for instance, whether a restoration survives 5–10 years without failure). The result is an abundance of lab-based papers and a relative paucity of high-quality clinical trials. One analysis found that dental randomized controlled trials (RCTs) often involve only on the order of tens of patients, far smaller than typical medical trials, limiting statistical power and generalizability. (For example, a review of orthodontic RCTs reported a median of about 60 patients per study, and many dental materials studies enroll far fewer.) Moreover, truly long-term clinical trials in dentistry – those lasting a decade or more – are exceedingly rare due to practical difficulties and cost. The solution is not to abandon laboratory research, which remains essential for early-phase discovery, but to better bridge it with clinical validation. Promising innovations should be followed by rigorous clinical trials with sufficient duration to assess real outcomes like restoration longevity or patient-centered results. In medicine, it’s expected that before a new drug or device is widely adopted, multiple large trials in humans have demonstrated its efficacy and safety. Dentistry needs a similar commitment to clinical evidence. Unfortunately, the current reality is that many dental interventions enter routine practice with minimal clinical trial evidence, relying instead on manufacturer testing or short-term surrogate outcomes.
Small Trials, Methodological Flaws, and High Risk of Bias
When clinical studies are performed in dentistry, they often suffer from methodological weaknesses. The average sample size of dental clinical trials tends to be low – often only on the order of a few dozen patients per group – which increases the risk of random errors and false findings. One review of general dentistry journals over a recent period identified only 67 RCTs out of 1,755 studies published, with an average of 358 participants per trial (a number likely skewed by a few larger studies). More telling was the quality: the authors found a “high percentage of unclear risk of bias” in these trials, indicating poor reporting and probable methodological issues. In fact, nearly half of the trials had an overall unclear or high risk of bias, meaning key safeguards (like proper randomization, allocation concealment, or blinded outcome assessment) were not adequately described or possibly not done. This pervasive risk of bias undermines confidence in the results. It also means that when these trials are aggregated in systematic reviews, the conclusion is often that the evidence is of “low quality” or too inconsistent to draw firm conclusions. Many Cochrane reviews in oral health, for example, end up finding insufficient or very low-certainty evidence for common interventions, reflecting the shaky foundation of primary studies.
Another concern is the flexibility researchers have in analyses – sometimes termed “P-hacking” or outcome switching – which can inflate false-positive results. With small sample sizes, it’s tempting (even subconsciously) for investigators to analyze multiple outcomes or time points and then report only those with statistically significant differences. Basic statistical tests can thus be cherry-picked to find some difference favoring a new product or technique, even if it might be a chance finding. Without stringent protocols or larger confirmatory trials, such results may not replicate. This helps explain why dental literature can be “full of contradictory findings” – one study reports a significant benefit of a material or treatment, while another finds no difference. In many cases, the contradictory results are due to each study being underpowered and at risk of various biases, so outcomes bounce around unpredictably. Reproducibility is a challenge: often the methods are not standardized enough for others to repeat, or the sample is too specific, resulting in one-off conclusions that fail when tested in a broader context.
A stark illustration is the systematic review process itself. When researchers attempt to perform systematic reviews or meta-analyses in dentistry, they frequently encounter heterogeneity and bias that prevent clear answers. It’s not uncommon for a dental systematic review to conclude that “no definitive recommendation can be made due to the low quality and heterogeneity of the included studies.” Indeed, one meta-epidemiological study of oral health trials found that only about 16.7% of trials had a “low” risk of sponsorship bias, whereas 72.8% were deemed “unclear” and over 10% high risk. This sponsorship bias (often linked with industry funding, discussed later) was associated with significantly larger effect sizes in those trials – suggesting that many positive findings might be exaggerated. Similarly, risk of bias from other sources (like lack of blinding or improper randomization) can distort outcomes. The upshot is that nearly half of published dental studies may not be reliable, which severely limits our ability to synthesize evidence. For frontline clinicians, this means guidelines are often based on shaky ground or expert opinion rather than robust data.
In summary, the methodological shortcomings – small trials, design/reporting flaws, and bias – produce a dental literature where confidence is limited. As a result, dentists face a cacophony of studies pointing in different directions and must often fall back on personal experience or anecdote. This erosion of confidence in research evidence feeds a cycle: practitioners become less inclined to trust or read research (“it’s all contradictory anyway”), and researchers struggle to secure funding to do larger, better trials, perpetuating the problem. Breaking this cycle will require deliberate efforts to improve trial design and reporting in oral health research. Wider use of reporting standards like CONSORT for RCTs, registering study protocols in advance, conducting a priori sample size calculations, and utilizing core outcome measures can help. In fact, initiatives are underway to develop core outcome sets for various dental fields – for example, a recent international consensus established a core set of mandatory outcomes for implant dentistry trials. Such standardization would allow results of different studies to be more easily compared or combined, reducing inconsistency.
Contradictory Findings and Limited Confidence in Evidence
Because of the issues above, dental research outcomes have frequently been inconsistent or outright contradictory, leading to confusion among clinicians. Nearly every dentist can cite examples where one journal article claims a certain intervention is superior, only to find another article refuting it. Reproducibility – a cornerstone of scientific confidence – is often lacking. One cause is that many studies are simply too underpowered to detect anything but very large effects, so when one study happens to find a “significant” result (perhaps by chance), a slightly different replication might not. Additionally, the range of methodologies and outcome measures used means two studies on “the same” question may not be truly comparable. For instance, one composite filling study might define success as lack of fracture at 2 years, whereas another looks at marginal discoloration at 5 years. Both might be valid in context but could lead to different impressions of what material is “best.” When a systematic review tries to combine such studies, it often concludes that due to heterogeneity no clear consensus can be drawn.
The consequence is a literature that fails to provide definitive answers for many everyday clinical questions. For example, dentists have debated for decades about topics like: “Which bonding agent yields the best long-term outcomes?” or “Does flossing actually reduce caries and gum disease significantly?” In an ideal scenario, high-quality trials and meta-analyses would give clear guidance. Instead, the evidence has often been inconclusive or feeble, leading to mixed messages. A prominent case that made headlines was flossing: a 2016 investigation by the Associated Press found that the evidence for flossing was surprisingly weak and unreliable. The AP reporters noted that “25 studies in leading journals found evidence for flossing is ‘weak, very unreliable,’ of ‘very low’ quality, and carries ‘a moderate to large potential for bias.’”. One review even concluded that the majority of studies “fail to demonstrate that flossing is generally effective in plaque removal.” This led U.S. and U.K. health authorities to quietly soften or reconsider formal flossing recommendations. The flossing example underscores how a lack of strong evidence can undermine even long-standing clinical advice and create public confusion. Dentists on the ground were left having to explain to patients why they should still floss despite news reports questioning its value – essentially falling back on clinical experience and biological rationale (“it makes sense to clean between teeth”) rather than being able to point to incontrovertible studies.
Such scenarios erode confidence in dental research for both practitioners and patients. Dentists often default to what “works in my hands” – a phrase commonly heard in the profession – instead of what is proven in studies. If the literature seems full of conflicting results, a practitioner might reasonably decide to trust their own clinical experience over a paper that might be overturned next year. Indeed, surveys and anecdotal evidence suggest many dentists do not rigidly follow published evidence if it contradicts their personal or mentors’ experience. While experience is valuable, over-reliance on intuition can perpetuate outdated practices and resistance to beneficial innovations. The overall effect is that only a small fraction of routine dental care may actually be evidence-based in the strict sense. One oft-cited estimate (attributed to Dr. Gordon Christensen, a prominent educator) is that perhaps only around 8% of dental clinical practices are based on peer-reviewed, critically appraised evidence. Although this figure is not from a formal study and should be taken as an illustrative point, it highlights the concern that much of what is done in dentistry is driven by tradition, personal preference, or commercial influence rather than solid science.
This contrasts starkly with medicine, where evidence-based guidelines are more engrained (though not perfect). In many medical specialties, practitioners are expected to keep up with the latest high-level evidence and incorporate new guidelines within a short time frame. In dentistry, there has historically been less of that expectation or infrastructure for translating evidence into practice, as discussed in the next section. Ultimately, the prevalence of contradictory findings calls for a doubling down on research quality and collaboration. The more that dental researchers can work together on large, multicenter trials using standardized protocols, the more likely we are to get reliable answers. Additionally, improving the transparency of research (publishing protocols, reporting all results, including negative findings) can help reduce the publication bias that often tilts the literature towards positive, but potentially spurious, outcomes.
Slow Adoption of Evidence-Based Practices in Dentistry
Even when good evidence does exist, dentistry has a notorious lag in incorporating research findings into everyday practice. In the broader healthcare context, it’s been said that it takes an average of 17 years for only a portion of research evidence (perhaps ~14%) to be fully integrated into clinical practice. This statistic – originating from analyses of translational science – is sobering on its own. What’s more concerning is that dentistry may be on the slower end of that spectrum. According to one review on knowledge translation, the 17-year figure can vary and in some cases might be even longer depending on the start and end points considered. Dentistry, as a field, has historically not been at the forefront of rapid translation of evidence. In fact, implementation science experts have noted that disciplines like oncology and mental health have far more advanced dissemination and implementation research compared to dentistry. This suggests that oral health care lags behind in systematically closing the “know-do gap.”
A frequently cited observation is that “dentistry changes at a glacier pace.” For instance, if high-quality research today showed a certain new treatment significantly improves outcomes, many dentists might not adopt it for a decade or more – if at all – absent an industry push or changes in the standard of care defined by licensing or specialty boards. Part of this slow uptake is cultural. The dental profession has prided itself on craftsmanship and individual expertise. Clinical autonomy is highly valued, and there isn’t always a strong external mandate to change practice based on research. In medicine, hospitals and professional bodies might enforce new evidence-based protocols (consider how quickly cardiologists responded to new stent trials or how oncologists embrace new chemo regimens supported by trials). In dentistry, a solo practitioner can largely continue practicing as they see fit, as long as they meet basic standard-of-care definitions, which are often broad. There is a saying among dentists: “It works in my hands, so I’ll keep doing it this way.” This mentality places personal experience on a higher pedestal than any published paper.
Why does this mentality persist? For one, as discussed, the literature’s inconsistency makes it easy to dismiss: for any study that suggests one should change approach, a skeptical dentist can find flaws in it or point to another study disagreeing. Additionally, many dentists lack formal training in evidence appraisal, making it challenging to digest and trust new research. Another key factor is simply information overload and accessibility – there are myriad dental journals (spanning general dentistry and all specialties), and many are behind paywalls. It is unrealistic for a busy clinician to read them all, and it’s difficult to even identify which evidence is high-quality amid the noise. Unlike medicine, where a few top-tier journals (NEJM, JAMA, Lancet, etc.) and guidelines are widely followed, dentistry’s research is scattered. A general dentist might have to follow dozens of niche journals to catch all relevant updates, which few have time for. Without a strong tradition of respected clinical practice guidelines, new evidence often doesn’t reach practitioners in a digestible form.
Studies on adoption of specific dental guidelines demonstrate the lag. For example, the concept of evidence-based dentistry (EBD) was introduced to the profession in the 1990s, and the American Dental Association and other bodies have since developed clinical recommendations (on topics like caries management, antibiotic use, etc.). Yet, surveys show many dentists are either unaware of these guidelines or choose not to follow them strictly. In one illustrative case, the ADA and American Association of Endodontists recommend use of a rubber dam for all root canal treatments (a well-supported safety and quality measure). However, a national study found that only about 47% of general dentists always use a rubber dam during root canals, and around 17% use it almost always – meaning a significant proportion do not adhere to this evidence-based standard. These numbers had barely improved from studies decades earlier, indicating stagnation in practice change. The reasons given include habit, the extra time or perceived patient discomfort, and again the belief that “I’ve done it without problems for years.”
The slow adoption is also quantifiable in extreme cases. One often hears the claim that it can take “20 years” for a new dental material or technique to be fully embraced by the majority of practitioners. This is partly because many clinicians prefer to wait and see if a new trend is a fad or truly beneficial. In medicine, that caution is healthy, but it is usually balanced by definitive trials that, once positive, rapidly shift practice. In dentistry, even after evidence emerges, there is seldom the same immediate paradigm shift. For example, scientific evidence linking periodontal health to systemic conditions (like diabetes control or cardiovascular disease) has grown strong in the last 20 years. Yet, integration of dental and medical care remains limited, and many dentists have not substantially changed how they manage periodontal disease in light of its systemic implications – in part because formal guidelines and reimbursement models have not caught up, and the “standard” way of practicing remains deeply ingrained.
The implications of slow evidence adoption are significant. Patients may not receive the best possible care because new, proven interventions are not widely implemented. Conversely, some outdated or ineffective practices may persist simply because “that’s how we’ve always done it.” This inertia in practice contributes to variability and can undermine health outcomes. It also means that investments in research are not yielding returns in improved patient health as quickly as they should. As one implementation science paper noted, it’s disheartening that even after years, only a fraction of evidence-based practices achieve widespread use.
Addressing this challenge will require bridging the gap between research and practice. Some strategies include: improving continuing education to be more evidence-focused, developing user-friendly summaries of new research (as journals like Journal of Evidence-Based Dental Practice attempt), creating more formal clinical practice guidelines and pathways in dentistry, and perhaps most importantly, cultivating a culture where staying up-to-date is part of professional duty. In medicine, for instance, there is an expectation (especially in hospital or academic settings) that providers follow the latest guidelines – with dental practice often being in more isolated private offices, that peer pressure or expectation is weaker. Encouraging more dentists to participate in study clubs or online forums that discuss new evidence could also help. The rise of practice-based research networks in dentistry is one promising avenue: these networks involve practicing dentists in research and dissemination, helping to create “early adopters” who can influence peers. Ultimately, shrinking the evidence-to-practice gap in dentistry will be crucial for the profession to truly claim it is delivering state-of-the-art care.
Research Silos and Lack of Interdisciplinary Collaboration
Another structural weakness in dental research is the siloed nature of the field. Dentistry has traditionally been somewhat insular, developing its own research culture and literature that does not heavily engage with other scientific disciplines. A bibliometric analysis of dental research publications from 2000 to 2015 starkly demonstrated this silo effect. It found that 85.5% of all references in dental journals were to other dental journals. In other words, dental researchers overwhelmingly cite work from within the dental field. Only roughly 14–15% of references were to medical or basic science journals, indicating limited knowledge exchange with outside disciplines. The analysis further noted that while dental schools have increased their research output in basic sciences, the “knowledge input from basic science into dental research did not increase.”. This suggests a one-way drift: dental researchers publishing in basic science venues or doing laboratory work, but not necessarily integrating insights from those broader fields back into solving dental clinical problems. The authors concluded that this “academic drift” – a tilt toward fundamental research and away from applied dental research – “has increased the disbalance towards basic science, and presents a challenge for scientific progress in dental healthcare services.”.
The implications of disciplinary silos are manifold. For one, dentistry deals with complex biological and bio-behavioral problems: dental caries is essentially an infectious disease modified by diet and host factors; periodontal disease involves immune-inflammatory pathways and systemic interactions. Solutions to these problems could benefit greatly from collaboration with microbiologists, immunologists, nutrition scientists, behavioral psychologists, epidemiologists, and more. Yet, if dental researchers “speak their own language” and publish mostly in dental journals with outcomes only dentists use (e.g., a “decayed, missing, filled teeth (DMFT) index” or “bleeding on probing”), it is difficult for scientists in other fields to engage or even understand the significance. As an example, dental studies often measure outcomes like “furcation involvement reduced by X mm” or “bond strength in MPa” – metrics that make sense to dentists and dental materials scientists, but are not easily interpreted in terms of patient health or general biology by outsiders. A commentary on oral health outcomes noted that common indices like DMFT “do not necessarily indicate the relative state of oral health or disease severity” and are “not directly relevant to consumers’ overall health”. They fail to capture quality of life impact or connect to metrics used in other health fields. This lack of common outcome measures means oral health often remains excluded from broader health policy discussions. For instance, public health officials might focus on metrics like Disability-Adjusted Life Years (DALYs) or quality-of-life scores, whereas dental metrics aren’t translated into those terms readily. Indeed, DALYs and QALYs (quality-adjusted life years) are “commonly used in other health fields but not well applied in oral health” research.
The silo problem also runs in the other direction: the medical and scientific community at large has historically paid limited attention to oral health research, partly because it’s separated. Oral health has been described as the “neglected stepchild” of health care. In 2019, a landmark Lancet series on oral health argued that oral health has been isolated from mainstream healthcare and health policy for too long. It emphasized that dentistry needs to integrate more with primary care and general health systems. The lack of integration means potential synergies are missed. For example, we know poor oral health can adversely affect nutrition and is linked to systemic diseases like diabetes and heart disease. However, research bridging dentistry and medicine (such as trials to see if treating periodontal disease improves diabetes outcomes) have been relatively few, and those that exist often struggle to get traction or funding. When oral health researchers do not collaborate with endocrinologists or cardiologists, such important interdisciplinary questions may remain unanswered. Conversely, medical research on chronic diseases often overlooks oral health status as a variable, which could be significant.
There are areas where dentistry could learn from other fields if silos were broken down. For instance, in orthopedics and plastic surgery, there is extensive research on bone grafting, tissue engineering, and wound healing that is highly relevant to dental implantology and periodontal regeneration – yet not always cross-referenced. Similarly, advances in microbiome research and immunotherapy in medicine could inform new approaches to managing dental caries and oral infections. The bibliometric data suggests that historically, dental journals seldom cite this external research, indicating missed opportunities to import knowledge. By the same token, dentistry has unique expertise in dealing with biofilms (dental plaque is one of the most studied biofilms) and in long-term biomaterial implants in a hostile oral environment. These insights could benefit other fields (for example, understanding biofilm resistance could inform catheter-related infection research), but such cross-pollination requires reaching audiences beyond the dental sphere. Currently, only ~15% of dental journal citations go to outside fields, which underscores how inward-focused the literature is.
Encouragingly, there are signs of change. More dental researchers today seek interdisciplinary grants and publish in general science journals. Topics like the oral microbiome’s role in systemic disease, or using machine learning on dental images, inherently involve broader collaborations. Organizations like the National Institutes of Health (NIH) have also started initiatives to integrate oral health into general health research. The National Institute of Dental and Craniofacial Research (NIDCR) participates in trans-NIH projects on microbiomes, regenerative medicine, and health disparities. However, to truly break silos, cultural shifts are needed: dental scientists must make an effort to “translate” dental problems into fundamental scientific questions that attract other experts. This might mean framing oral diseases in terms of inflammation, infection, oncology (for oral cancer), etc., and publishing in those realms. The Lancet oral health series explicitly called for oral health to be part of the universal health coverage movement and linked with other noncommunicable disease efforts. It also highlighted that the “oral–systemic health” link, while supported by evidence, hasn’t been leveraged enough – largely due to the separation of dental care systems from medical care.
In summary, research silos have hindered innovation in dentistry. By speaking only to each other, dental researchers risk reinventing the wheel or missing cutting-edge developments elsewhere. The consequence is slower progress and a narrower pool of ideas to draw from. Breaking out of these silos by fostering interdisciplinary research and using more universally understandable outcome measures could accelerate discovery. For the dental practitioner and patient, this could translate to more effective treatments that draw on the best of all sciences, not just what has been done before within dentistry.
The Influence of Industry and Funding Constraints
Scientific research does not occur in a vacuum – it is influenced by who pays for it and what questions get prioritized. In dentistry, industry influence is notably strong, and overall research funding is disproportionately low relative to the importance of oral health. Both factors contribute to weaknesses in the evidence base.
The dental industry (manufacturers of dental materials, instruments, implants, pharmaceuticals, etc.) plays a substantial role in funding research, especially for product evaluation. Many clinical trials and studies of new dental products are sponsored or supported by the companies that make them. This introduces potential conflicts of interest and bias. A consistent finding in the wider scientific literature is that industry-sponsored trials are more likely to report favorable outcomes for the sponsor’s product than independent trials. Dentistry is no exception. For example, in the field of dental implants, a systematic review in PLOS ONE examined the effect of sponsorship on reported implant success rates. It found that trials funded by implant companies reported significantly lower failure rates (i.e. higher success) than trials without industry funding, even after controlling for other factors. Specifically, the odds of implant failure were markedly lower in industry-associated trials (OR ~0.21) compared to non-industry trials. The authors bluntly concluded that “when controlling for other factors, the probability of annual failure for industry associated trials is significantly lower” than for non-industry trials. In practical terms, some company-sponsored studies have boasted near-100% success rates over short follow-ups, results that seem almost too good to be true and are seldom mirrored in broader clinical experience or independent long-term studies. A meta-epidemiological analysis across various oral health interventions similarly found that trials at high or unclear risk of sponsorship bias showed on average 10% larger treatment effects than trials at low risk of such bias. These findings strongly suggest the presence of sponsorship bias – whether through subtle differences in study design, selective reporting, or publication bias (unfavorable studies not getting published).
Moreover, industry funding tends to skew what gets researched. Companies are naturally interested in studies that will help market their products – for instance, comparisons between their new material and an older one, showing improved results in the lab or short-term clinical performance. Thus, the dental literature is replete with “product comparison” studies: one bonding agent vs another, one brand of composite vs another, etc. While useful, these studies often focus on minor differences and laboratory end-points that align with marketing needs (like bond strength rankings or polishability scores). Areas of research that do not promise an immediate financial return receive far less attention. For example, preventive dentistry, public health measures, or studies addressing oral health disparities and behavior change are relatively underrepresented. There is no big corporation with a vested interest in funding a community water fluoridation impact study or a dietary intervention for caries prevention (in fact, industries selling sugary foods might prefer such research not be done). The Lancet oral health critique pointed out that dentistry’s focus on treatment and high-tech interventions has meant insufficient attention to underlying causes like sugar consumption. In fact, the sugar industry has historically had a conflict of interest with dental research: documents have revealed that in the 1960s, sugar industry groups influenced dental research directions to deflect attention from sugar’s role in caries, instead promoting research into “tooth-friendly” measures like enzymes or vaccines that never panned out. Even today, the Lancet series noted that “the sugar industry is influencing dental research, oral health policy, and professional organizations through its well-developed corporate strategies.” They called for clearer conflict of interest policies to limit industry’s sway on research agendas. As an example, a commentary in The Lancet by Kearns and Bero (2019) highlighted that dental research organizations often receive sponsorship from sugary food and beverage companies, potentially compromising the focus on sugar reduction strategies. The consequence is that fundamental prevention questions – like how best to reduce population sugar intake or tobacco use to prevent oral disease – are relatively under-researched, while incremental innovations in restorative materials get ample study.
Compounding the bias issue is the sheer lack of funding in dentistry for independent research. Oral health research has long been underfunded by national health agencies. In the United States, the NIDCR’s budget is only a small fraction of the overall NIH budget. Around 2014, it was reported that the NIH’s extramural awards to dental institutions comprised only about 0.9–1.1% of the NIH budget. This is strikingly low given that oral diseases are among the most prevalent health conditions globally. For context, the burden of oral diseases (in DALYs or number of people affected) rivals that of major diseases like diabetes or mental illnesses, but funding is not commensurate. A recent analysis in Australia similarly found that oral health receives the lowest and most inequitable government research funding relative to disease burden. Between 2017–2021, Australia’s national medical research fund (NHMRC) allocated only about $15 million to oral disorders, which was far below what would be expected for the share of disease they cause. This amounted to only 0.23% of the government’s research funding going to oral health, despite oral diseases affecting nearly everyone at some point. In other words, oral health is an underfunded orphan in research terms.
The impact of chronic underfunding is severe. It leads to fewer large-scale clinical trials because those are expensive. It also results in a limited pipeline of PhD-level dental researchers – talented individuals might opt for other biomedical fields where funding and career prospects are better. Indeed, there has been concern about a “talent drain,” with fewer dentist-scientists being produced. If grant success rates in dental research are low, young researchers may be discouraged from pursuing academic careers in dentistry, opting instead for fields with more robust support. Over time, this threatens the innovation capacity of the profession. An editorial from Harvard’s dental school warned that federal funding cuts “threaten dental research … putting scientific progress, patient care, and economic growth at risk.”. Another effect is that dental schools and researchers become more reliant on industry partnerships to fund studies, which loops back into the conflict-of-interest cycle.
Because resources are scarce, research questions that get investigated tend to be those that align with available funding streams. As mentioned, companies will fund work on their products; government funds might emphasize areas like head and neck cancer or HIV-related oral health (due to larger public health initiatives), but less so everyday dental practice questions. This misalignment has been termed “academic drift” – researchers gravitating to where funding is, which might be basic science or trendy topics, rather than the practical clinical questions dentists need answered. A bibliometric study noted that by 2010 about half of the research output of Dutch dental schools was in basic sciences, not applied clinical research. It’s not that basic science is bad – it is crucial – but if it comes at the expense of applied research, then pressing clinical problems remain unsolved. For example, a dentist in practice might want to know the best protocol to arrest early tooth decay without drilling. While some research exists on methods like fluoride varnish, silver diamine fluoride, or sealants, those preventive studies often lack the large, definitive trials to make every dentist change approach. Meanwhile, a well-funded basic science lab might be examining, say, the genetics of tooth development – valuable knowledge, but it might not translate into patient care for decades. The drift occurs because academia rewards publications in high-impact journals (often basic science journals) and obtaining grants, which pushes researchers toward topics that those journals and funders favor. The unfortunate consequence is that the knowledge flow back to clinicians is diminished. As van der Wouden et al. (2022) observed, “the dental research portfolio has moved away from research that serves dental healthcare… presenting a challenge for scientific progress in dental healthcare services.”.
In simpler terms, patients and practicing dentists may not feel the benefit of much of the academic research being done, because it’s either too fundamental or too focused on niche product outcomes. Meanwhile, many everyday clinical decisions still lack high-level evidence, as discussed earlier. All these issues link back to funding priorities and sources.
Addressing industry influence and funding gaps is complex. Some recommendations include: enforcing more rigorous disclosure of conflicts of interest and perhaps independent replication of industry-funded results before they influence guidelines. The dental community and funding agencies could push for more publicly funded, large clinical trials in key areas of oral health (similar to how NIH funds big trials in medicine). There have been some moves, such as the establishment of practice-based research networks (PBRNs) that conduct multi-center studies in real-world dental offices with NIH support. These networks have yielded studies on topics like caries management that involve hundreds of practitioners and patients, which is a positive step. Additionally, advocating for a bigger slice of health research budgets for oral health is crucial. Oral diseases account for a substantial global health burden (estimated 3.5 billion people affected), so allocating only ~1% or less of research funds to them is a moral and practical shortfall. The Lancet calls for oral health to be included in general health and policy initiatives – one can infer that includes research funding integration as well.
Finally, tackling the influence of commercial determinants requires the profession to sometimes take stances that may be uncomfortable. For example, confronting the sugar industry’s role in driving caries through policy advocacy (taxes on sugary drinks, etc.) or speaking out about tobacco control as a means to reduce oral cancer and periodontal disease. These are evidence-based public health measures that dental organizations should champion, yet historically they have sometimes been muted, possibly due to entanglements or focusing inward on clinical dentistry. A refocusing on prevention and public health – backed by robust research – could greatly amplify dentistry’s impact, but it needs funding and the will to possibly challenge powerful commercial interests. As the Lancet series poignantly stated, “coherent and comprehensive regulation and legislation are needed to tackle [the] shared risk factors” of sugar, tobacco, and alcohol that drive oral and other diseases. That includes ensuring research isn’t quietly steered away from those topics.
In summary, the influence of industry and the dearth of independent funding have shaped a dental research landscape that sometimes emphasizes products over patients and leaves critical questions under-examined. Recognizing and correcting these imbalances is vital for a more trustworthy and relevant evidence base.
Misalignment of Research with Clinical Needs (Academic Drift)
One of the subtler but significant weaknesses in dental research is the mismatch between what researchers study and what clinicians (and patients) truly need answered. This academic drift was touched on above regarding funding, but it’s worth examining from the perspective of its impact on clinical practice. Every practicing dentist has a list of practical questions: “Which restorative material will last the longest in a high-risk patient with heavy bite forces?”; “What’s the most effective way to manage early caries non-invasively?”; “How often should we recall patients for cleanings to actually improve health?”; “Does doing X procedure really improve outcomes or is it unnecessary?” Ideally, dental research should systematically address these kinds of questions so that evidence-based guidelines can inform practice. In reality, many of these day-to-day questions either have no high-quality studies, or the studies exist but are not synthesized into clear guidance.
One example of where research drifted away from clinical utility is the evolution of periodontal disease classification. For decades, periodontists used a classification (from 1999) that categorized periodontal disease as “chronic” or “aggressive,” localized or generalized, etc. This system had issues – it wasn’t strongly tied to actual prognosis or patient-centered outcomes – and in 2017 a new global classification was introduced. The 2017 World Workshop on periodontal diseases created a more complex staging and grading system that incorporates severity, extent, and risk factors (like smoking or diabetes) to predict disease progression. Scientifically, this was a step forward because it attempted to link the clinical assessment with meaningful outcomes (risk of tooth loss over time, etc.). However, the new system is quite intricate, with multiple steps to determine stage and grade, and it has been challenging to implement widely. Many general dentists and even some periodontists have been slow to adopt it fully into practice, finding it cumbersome. Part of the problem is that the new classification, while more evidence-based, isn’t required or incentivized in everyday practice. Dental insurance coding, for example, still doesn’t mandate or necessarily accommodate these new classifications, often sticking to older terminology (e.g., “advanced periodontitis” vs specific stage/grade). This means clinicians don’t have to change, and many haven’t. This micro case reflects a broader theme: research can produce a better system or method, but if it’s too complex or not translated into user-friendly tools, it may not penetrate practice for a long time. It highlights the importance of implementation research – it’s not enough to discover something, one must also figure out how to get it adopted. In periodontology, efforts are ongoing to educate and simplify the new classification for practitioners, but uniform uptake remains a work in progress several years on.
More generally, the content of dental journals has tilted toward topics that do not directly help a dentist decide how to treat a patient Monday morning. The bibliometric study of 2000–2015 noted that the share of output from dental institutions in clinical dental journals actually declined, while output in basic science journals increased. So dental schools are publishing more in places like Biomaterials or Cell Science, and relatively less in applied clinical outlets. Additionally, even within clinical research, a lot of studies explore marginal gains or are exploratory in nature. To illustrate, one might find numerous clinical trials comparing slight variations of a procedure (etching times, curing light types, implant surface modifications) which, while important, may not address larger questions like “Do my patients do better with intervention A or B over 10 years?” Meanwhile, broader issues such as best strategies for managing patients with severe anxiety, or long-term outcomes of comprehensive care vs extraction-and-denture in low-income populations, get less attention academically because they are harder to fund or publish (they may be seen as less novel scientifically even if very relevant clinically).
This drift is recognized by clinicians, many of whom feel that “a lot of stuff in journals isn’t relevant to what I do.” If practitioners perceive academic research as esoteric or disconnected, they are less likely to engage with it, deepening the research-practice gap. It also means that some pressing clinical problems remain unsolved. For instance, dental caries (tooth decay) is still treated largely the same way it was 50 years ago when it reaches the cavitation stage – by drilling and filling. Preventive measures like fluoride have certainly improved things, but once decay sets in, we mechanically remove it and restore the tooth. Is that really the best we can do, biologically speaking? Could there be a way to truly remineralize and regenerate tooth structure at a clinical level? Research into non-surgical caries treatments exists (like fluoride varnishes, silver diamine fluoride, resin infiltration, etc.), but one could argue it has not been a top priority compared to, say, developing ever stronger dental adhesives or more esthetic ceramics. The latter yield more straightforward lab studies and product development opportunities, whereas the former requires behavioral science, clinical trials in community settings, and tackling diet – areas that don’t attract as much academic glory or industry backing. Thus, the research portfolio ends up imbalanced relative to the actual disease burden and needs. The Lancet series bluntly stated that the current dental care approach in high-income countries is “not tackling the underlying causes of disease and not addressing inequalities in oral health.” They call for a shift toward health promotion and disease prevention. For research, this means focusing on things like effective prevention in high-risk groups, implementation of known preventive measures, and broader social determinants of oral health.
Another angle of academic drift is reliance on industry for innovation. If academia isn’t solving clinical problems, often the gap is filled by commercial entities that develop a product and market it as the next solution. While industry R&D has led to many advances (e.g., new implant designs, CAD/CAM technology, etc.), it also means that some questions get answered by what is commercially viable rather than what is necessarily clinically most important. For example, we see constant incremental improvements in restorative materials (Gen-8 bonding agents, bulk-fill composites, etc.), many of which do provide some benefit, but how often do we see a breakthrough in, say, preventing root caries in the elderly or effectively treating peri-implantitis? Those latter topics might require concerted research efforts without immediate profit, which academia/government would have to champion.
The consequences of this drift and misalignment are significant for patients. It contributes to why, despite so much scientific advancement in general, we still face global oral health crises. Dental caries remains the number one disease globally in terms of prevalence – as of 2017, an estimated 2.3 billion people had untreated caries in permanent teeth. Periodontal disease is highly prevalent as well, with severe periodontitis affecting around 10% of the population (796 million cases globally in 2017) and moderate forms affecting many more. These numbers have not dramatically improved over decades. A report noted that the global prevalence of untreated caries was basically unchanged between 1990 and 2010. That suggests that while we have been improving materials and techniques at the micro level, at the macro level we are barely denting the disease burden. Researchers spending more effort on practical prevention and public health implementation could make a bigger dent, but that requires realigning incentives and focus.
To combat academic drift, some have suggested creating more “applied research” funding streams in dentistry. For example, funding that specifically calls for clinical trials answering everyday questions or comparative effectiveness research in oral health. Also, academic promotion criteria could value practice-oriented research more, not just basic science and lab studies. The concept of “Practice-Based Research Networks” (PBRNs) again comes into play: by involving practicing dentists in research, the studies are more likely to be grounded in practical questions and the results disseminated directly to practitioners. Another idea is core outcome sets tailored to measure what actually matters to patients and clinicians. For instance, in caries research, instead of just measuring reduction in lesion depth on an X-ray (a surrogate), a core outcome might be something like “tooth survival without painful intervention over 5 years” or patient-reported tooth sensitivity, etc. If researchers must use such outcomes, the relevance of studies would increase. In implants, a recent effort (the Implant Dentistry Core Outcomes Set initiative) identified a set of outcomes that all implant studies should report, covering not just implant survival, but also patient-centered outcomes and complications. This will help ensure that future trials answer questions meaningful for patient care (e.g., not just “did the implant integrate?” but “what was the patient’s quality of life and were there any complications or maintenance issues?”).
In summary, academic drift has led to a disconnect between research and real-world dental practice needs. Refocusing research agendas to address pressing clinical problems and patient outcomes, and making sure those findings circle back into practice, is essential. Otherwise, we risk continuing the status quo where scientific advances exist on paper but the daily experience of patients (pain, tooth loss, inequality in care) changes little.
Challenges in Standardization and Evidence Synthesis
Because of the varied and siloed nature of dental research, another weakness has been the lack of standardization in research methods and outcome measures. This lack of standardization makes it difficult to combine or compare studies, slowing the accumulation of actionable evidence. By contrast, many areas of medicine have developed standardized outcome definitions and large collaborative trials which allow data pooling and network meta-analyses to answer broad questions. Dentistry has been slower to adopt these practices, though improvements are underway.
For a long time, different studies measuring ostensibly the same thing in dentistry did so in different ways. Take, for instance, something as simple as “restorative success.” One researcher might define success of a filling as “no need for replacement at 2 years,” another might have a detailed criterion including marginal integrity, patient satisfaction, etc., and report success at 5 years, while another might report mean change in lesion depth. Similarly, periodontal studies historically reported outcomes like “probing depth reduction” or “clinical attachment gain” but varied in how they measured or what threshold was considered clinically significant. Without common endpoints, performing meta-analysis is like comparing apples and oranges. Network meta-analysis (NMA) is a powerful tool that can compare multiple treatments even if they haven’t been directly compared in a single trial – but it relies on trials having enough commonality. In medicine, NMA has been used to rank drugs for a condition, for example. In dentistry, the use of NMA is still emerging, in part due to the heterogeneity of outcomes and the smaller trial pool. However, there have been some network meta-analyses in areas like restorative materials or endodontic treatments where enough trials existed. The problem is, if every trial uses different metrics (one uses pain on a 0-10 scale, another uses success/failure binary, another uses radiographic healing), it’s challenging to network them. The profession has recognized this and is moving toward core outcome sets (as mentioned). For example, a PLOS One article described work to develop a core outcome set for periodontal disease trials, aiming to get consensus on what outcomes should be consistently measured (e.g., tooth loss, patient-reported outcomes like chewing ability, etc.). The benefit of such standardization is huge: researchers can design studies that contribute to a larger body of evidence rather than standalone one-offs.
Another area of standardization is in reporting quality. As noted earlier, many dental trials had unclear risk of bias largely due to incomplete reporting. Guidelines like CONSORT (for trials) or PRISMA (for systematic reviews) exist to standardize reporting, and more dental journals are insisting on these, but adherence is not universal. Additionally, in dental materials research, a new tool called RoBDEMAT (Risk of Bias in Dental Materials Testing) was developed to guide authors in conducting and reporting lab studies more rigorously (ensuring, for instance, proper sample randomization, standardized storage conditions, etc., in lab experiments). This kind of initiative is important because a lot of clinical inference is built on lab data for materials, so if those studies are poor or incomparable, it weakens the chain of evidence.
Standardization efforts also extend to diagnostic criteria. In caries research, for example, the adoption of the ICDAS (International Caries Detection and Assessment System) provided a standardized way to classify lesion severity, which helps researchers compare studies of early caries. Likewise, periodontal research now often uses the 2017 classification scheme which, despite its complexity, at least unifies what “Stage III Grade C periodontitis” means in any study that uses it, facilitating comparison.
Despite progress, dentistry is still catching up to evidence-based methodology compared to medicine. In medicine, clinical guidelines often come with an evidence hierarchy and clear algorithmic flowcharts – essentially spoon-feeding clinicians the decision pathway based on best evidence. In dentistry, with notable exceptions, such decision trees are rarer. Many treatment decisions are left to individual practitioner judgment, which is why one dentist might choose to watch a shallow cavity and another to fill it immediately – both thinking they are doing right, because no unequivocal guideline exists. There are efforts by organizations like the ADA to produce more clinical practice guidelines (e.g., on topical fluoride use, restorative thresholds for caries, managing third molars, etc.), which is a positive trend. These guidelines, when they exist, do evaluate and standardize evidence. For instance, the ADA’s caries management guidelines incorporate evidence on risk assessment and when to intervene surgically vs. non-surgically. The challenge is ensuring such guidelines are comprehensive and kept up to date, which requires synthesizing new research continuously – a task made harder if the research is not standardized or robust.
One encouraging development is the modern “toolkit” of statistical and study design methods being slowly integrated into oral health research. Cluster-randomized trials, stepped-wedge designs, or adaptive trials, which are used in health services research and medicine, are now appearing in oral health studies (for example, studies in community dentistry or prevention may randomize clinics or schools rather than individuals). The use of pragmatic trials – which test interventions in real-world clinical settings with broad patient inclusion – is also growing, thanks to PBRNs. These pragmatic studies help in creating results that are directly applicable to practice because they use ordinary patients and practitioners rather than idealized conditions.
Another aspect is statistical literacy in the profession. It’s one thing for researchers to produce sophisticated analyses (like logistic regressions or survival analyses of treatments), but if the average reader cannot interpret the findings, the impact is lost. There is an educational need to improve how dentists consume research. Journals and continuing education can help by explaining results in clearer terms and focusing on clinical significance, not just statistical significance. Some journals provide plain-language summaries or “clinical relevance” sections – these are useful tools to connect evidence to practice.
In terms of evidence synthesis, dentistry has a strong asset in the Cochrane Oral Health Group, which has systematically reviewed many topics. Cochrane reviews apply a standardized protocol to search and combine data and often highlight weaknesses in primary studies that need to be addressed. By following Cochrane’s identified gaps, researchers can target their studies to fill those. For example, if a Cochrane review says “evidence is very low quality, more RCTs needed on X,” that sets a research agenda. Aligning research efforts with those identified needs would improve the situation.
Overall, modernizing the research toolkit – through standard outcomes, better reporting, advanced trial designs, and improved synthesis – is gradually cutting through some of the confusion. The goal is that in the near future, when a dentist faces a clinical question, there will be a reliable body of evidence and perhaps an up-to-date meta-analysis or guideline to consult, rather than a conflicting set of small studies. In an ideal scenario, one could envision something like a constantly updated database (akin to a “dental UpToDate”) where for any intervention, the level of evidence and best practices are summarized. We are not quite there yet, but steps like standardizing research outputs will make it feasible.
Impact on Patient Care and Oral Health Outcomes
Ultimately, the weaknesses in dental research discussed are not just academic concerns – they directly affect patient care and health outcomes. When evidence is weak, inconsistent, or not translated into practice, patients receive variable care. This variability can mean the difference between health and disease, tooth retention or loss, comfort or pain, and even life or death in extreme cases (e.g., an undiagnosed oral cancer or an infection not properly managed).
One evident impact is the inconsistency in treatment planning and care strategies among dental practitioners. Studies have documented wide variations in how different dentists manage the same condition. For example, one classic study presented identical case information to multiple dentists and found a range of recommended treatments from minimal to aggressive. Even after controlling for patient factors, “variation in dentists’ clinical decisions is ubiquitous”, including fundamental decisions like when to diagnose decay or when to intervene vs. monitor. Such inconsistency partly stems from the lack of unequivocal evidence or guidelines. If the research doesn’t clearly say “Approach A is superior to Approach B for this scenario,” then each dentist relies on their training, intuition, or even patient preference to choose a path. From the patient’s perspective, this can seem like a lottery – one dentist says you need a filling, another says you don’t; one recommends a root canal, another says extraction and implant is better. Not only can this undermine trust in the profession, it also can lead to disparities in outcomes. Some patients might get over-treatment (with unnecessary costs and risks), while others get under-treatment (with problems worsening because intervention was delayed).
Another example is in preventive practices. There are evidence-based preventive measures (fluoride varnish for high-risk kids, sealants for molars, chlorhexidine or silver diamine fluoride for certain cases of early decay, etc.). Yet, adoption of these in daily practice is uneven. The earlier-mentioned statistic that only ~50% of dentists consistently use rubber dams in root canals illustrates how even a well-established standard isn’t universal. Similarly, consider silver diamine fluoride (SDF), a modality to arrest caries: research has demonstrated its effectiveness in stopping decay in certain populations, and many public health programs have embraced it. But in private practice, SDF (which stains the lesion black) has been slower to catch on, partly because of esthetic concerns and perhaps because it’s a “medical management” approach versus the traditional surgical fix. If research evidence were stronger and more integrated – for instance, if long-term studies showed significantly better outcomes and cost savings with SDF in specific cases – and if guidelines strongly recommended it, perhaps more dentists would offer it to patients who could benefit. Without that push, many patients may never hear of it and instead end up getting fillings or extractions that might have been avoidable.
The culture of valuing personal experience over evidence can also occasionally have more dire consequences. For instance, consider antibiotic prescribing. In the past, many dentists gave antibiotics liberally for dental infections or prophylactically. Evidence and guidelines now advise more cautious use to combat antibiotic resistance and side effects. If a dentist is not up-to-date or chooses to ignore those guidelines, patients might be overexposed to antibiotics, contributing to resistance or adverse reactions (like C. difficile infections). Conversely, under-use or the wrong antibiotic choice can let an infection spread. So evidence adherence truly matters for safety. Thankfully, in areas like infection management, there have been concerted efforts to educate and change practice, and antibiotic prescribing by dentists has been scrutinized and improved in some countries.
The oral-systemic health connection is another domain where incomplete evidence integration has kept dentistry somewhat siloed, to patients’ detriment. There is mounting evidence that untreated periodontal disease can adversely affect glycemic control in diabetes, and conversely that good dental care might improve it. There are associations between periodontal disease and heart disease, adverse pregnancy outcomes, etc. While causation and exact mechanisms are still studied, it’s clear the mouth is not an isolated island. As the user’s script noted, the mouth harbors billions of microorganisms and is the gateway to the body – problems there can have system-wide effects (for example, chronic oral inflammation raising systemic inflammatory markers, or oral bacteria seeding distant sites). Patients with poor oral health can have trouble eating, which impacts nutrition and general health. If dental research remains siloed and evidence isn’t effectively communicated, physicians and dentists might miss opportunities to co-manage patient health. For example, few medical guidelines strongly incorporate oral health screening (though this is changing slowly). And on the dental side, if a patient presents with periodontal disease and other risk factors, ideally a dentist would coordinate with their physician to check for diabetes and work on risk reduction together. Some progressive practices do this, but it’s not the norm. The Lancet advocated for integrating dentistry into primary care for precisely these reasons.
Inconsistent or slow-to-update evidence also affects patient expectations and education. If half of dentists are using a new method and half aren’t, patients may receive mixed messages or miss out on beneficial new approaches. Consider something like dental implants: the evidence shows high success rates in appropriate cases, and they’ve become a standard of care for replacing missing teeth. But if evidence on long-term outcomes in certain patient groups (say, smokers or diabetics) is limited, different dentists may have different thresholds for recommending implants vs. traditional dentures or bridges. A patient might get very different treatment plans from two consultations, which can be confusing. If research were clearer (e.g., a strong study showing even diabetics do well with proper management, or conversely that certain patients shouldn’t get implants), it would lead to more uniform recommendations.
The lack of strong evidence can also hinder the formulation of guidelines that would protect patients. For example, consider how many dental interventions have been questioned due to weak evidence: flossing (as mentioned), or things like “do wisdom teeth need to be removed prophylactically?” In the latter case, guidelines now advise against routine removal of asymptomatic wisdom teeth because evidence doesn’t support it in all cases, yet many are still removed based on tradition or presumed future risk. When guidelines say “we have no evidence to support doing X,” some practitioners interpret that as “so I can do what I want” instead of “so perhaps we shouldn’t do X.” The nuance is important: no evidence of benefit is not the same as evidence of no benefit, but it should caution us. However, in absence of clear directives, practice patterns vary widely. In areas where dentistry lacks good science, it becomes vulnerable to fads and anecdotal practices. Patients might be subjected to procedures that are popular but unproven (certain laser therapies, “no-drill dentistry” products, etc.) or they might miss out on effective care because it isn’t widely endorsed yet.
Ultimately, patients suffer the most when research is weak or ignored. They may receive suboptimal care, or unnecessary treatment, or pay more for newer treatments with unproven advantages. On a population level, failing to implement known effective strategies (like fluoride or sealants for kids, or smoking cessation programs) means preventable disease continues to occur. Oral diseases cause pain, infection, lost productivity at work or school, and expensive treatments – largely borne out-of-pocket worldwide. The persistence of a heavy disease burden (e.g., billions of carious teeth, millions with edentulism needing dentures) despite our advanced knowledge is a sign that the translation of evidence to impact has lagged.
Another patient-level impact is trust. If patients perceive that dentistry isn’t science-driven, but rather profit- or tradition-driven, it can erode trust. This is why it’s so important to openly embrace evidence-based practice – it shows patients that our recommendations are backed by rigorous study and not just upselling or personal bias. The flossing news story, for example, led some people to question dentists’ advice generally (“if they were telling us to floss all this time without evidence, what else are they pushing without evidence?”). While that perception isn’t entirely fair – flossing was always a low-risk recommendation with a logical basis – it underlines how the public expects health professions to be evidence-guided. If dentistry doesn’t continually strengthen its evidence base and follow it, it could lose credibility.
In contrast, where dentistry has solid evidence and has acted on it, patients have benefited enormously. A shining example is fluoridation and fluoride toothpaste – research showed their effectiveness in the mid-20th century, and broad implementation of fluoride has halved cavity rates in many countries. Another example is the reduction in smoking (not a result of dental research per se, but of public health evidence) which has helped lower rates of oral cancer and periodontal disease in places where tobacco use declined. These successes show what can happen when strong evidence is translated into widespread practice or policy. We need more such instances in other areas of oral health care.
Strategies for Strengthening Dental Research and its Impact
Having dissected the problems, it is worth focusing on solutions and improvements that can address these weaknesses in dental research. A multi-pronged approach is required, targeting research conduct, the dental profession’s culture, and the integration of oral health into the broader health sphere.
1. Emphasize High-Quality Clinical Research: To move past heavy reliance on bench studies, the field must invest in more well-designed clinical trials and observational studies that directly inform patient care. This means lobbying for more research funding from government and industry to be directed at clinically relevant questions, not just product development. It also means encouraging multi-center collaborations to achieve adequate sample sizes. If the average dental RCT size can grow from dozens to hundreds of participants (as often seen in medicine), the power to detect true effects and influence practice will grow. Additionally, researchers should design studies that reflect real-world conditions (pragmatic trials) so results can generalize. For example, rather than testing a new procedure only in a university clinic on ideal patients, include community clinics and diverse populations. This makes findings more applicable and convincing to practitioners in those settings.
2. Improve Research Training and Literacy: Both researchers and clinicians need a stronger foundation in evidence-based practice. For researchers, training in epidemiology and biostatistics (perhaps through joint degree programs or courses) can raise the quality of study design. For clinicians, evidence-based dentistry should be a greater part of the dental school curriculum and licensure exams. Dentists should graduate with skills to appraise research critically and the mindset that they should update their knowledge continuously. Continuing education courses can focus more on interpreting new evidence and less on just showcasing new products. In recent years, some dental schools have indeed integrated EBD projects into their programs – this trend needs to continue so that the next generation of dentists expects and demands solid evidence behind what they do.
3. Foster a Culture of Evidence Uptake: The “works in my hands” ethos needs to be balanced by “what does the evidence show?”. Dental organizations and leaders can help by setting expectations that members follow current best practices. Just as medical boards require physicians to stay current with guidelines, perhaps dental boards or associations could endorse certain standards of care based on evidence and update them regularly. Peer influence is powerful – thus, creating local study clubs or online forums where dentists discuss new research can normalize changing practice based on data. Recognizing and rewarding practices that implement evidence-based improvements (through awards or public case studies) could also motivate others. Over time, a cultural shift can occur where dentists take pride in being scientifically up-to-date, rather than viewing new evidence as an affront to their experience.
4. Break Down Silos – Interdisciplinary Collaboration: The artificial separation of dentistry from medicine and other sciences must end for the benefit of patients. Researchers should proactively collaborate across fields. For instance, include an oral health component in general health studies – like having dental exams or interventions in a diabetes management trial, to see if it improves outcomes. Conversely, involve medical experts in dental studies (e.g., cardiologists in periodontal trials) to lend broader perspective and methodologies. Funding bodies could encourage this by offering grants specifically for projects that link oral health with other health domains (some calls like this have started to appear). At the clinical level, increased interaction between dental and medical professionals is key. Integrating dental records with electronic health records, co-locating dental offices in medical clinics, or training medical providers in basic oral health assessment can facilitate a two-way exchange of information. Over time, such integration means oral health will be considered in mainstream guidelines for overall health (for example, ensuring cancer survivors have dental follow-up due to their treatment’s oral side effects, etc.).
5. Increase Research Funding and Independence: Advocacy is needed to boost funding for oral health research. Dental researchers and professional bodies can make the case to policymakers that oral health is integral to overall health and merits investment – pointing to the huge global burden and economic cost of oral diseases. If national research budgets allocate even a few percentage points more to dental/oral health topics, it could transform the field. With more public funding, reliance on industry dollars lessens, thereby reducing bias. Another approach is partnerships with large healthcare systems or insurers, who might have interest in funding studies that could improve care quality or reduce costs (e.g., a big insurer might fund research on non-surgical periodontal therapy if it could reduce costly complications down the line). For industry’s role, stricter conflict of interest policies and perhaps independent trial oversight can ensure that when industry-funded research is done, it adheres to transparency and can be trusted. Journals should continue to demand conflict disclosures and be wary of papers that read like marketing. Some have even suggested that dental research organizations (like the International Association for Dental Research, IADR) develop guidelines to manage industry partnerships ethically – for instance, ensuring academic freedom to publish regardless of outcome.
6. Standardize and Modernize Research Methods: As discussed, establishing core outcome sets in major areas (caries, periodontal disease, endodontics, implantology, etc.) will greatly help evidence synthesis. The profession should rally around these once developed, and journals could even mandate that studies report the core outcomes. Embracing open science practices – such as trial registries, data sharing, and preprints – can also accelerate progress and credibility. If data from studies are made available, independent analyses could verify results or pool data for larger meta-analyses. Adopting advanced data analytics like machine learning on large datasets (for example, mining thousands of dental records to find patterns) can generate real-world evidence to complement traditional trials. There is an increasing volume of digital dental data (digital scans, CBCT 3D images, electronic health records) that largely remains underutilized for research. Collaborations with computer scientists and statisticians can unlock this “big data” to answer questions on treatment outcomes, disease prediction, and more. For instance, AI algorithms have been developed to read radiographs and detect early signs of decay or even predict restorations at risk of failing. Such tools, if validated, can be integrated into practice, making care more preventive and personalized.
7. Focus on Prevention and Public Health in Research: Given the limited progress in reducing disease prevalence, a rebalancing toward prevention research is warranted. This includes studying how best to encourage healthy behaviors (e.g., effective school-based oral health education, testing sugar-reduction policies), evaluating community interventions (like the cost-benefit of school sealant programs or mobile dental clinics), and tackling access issues. Also, researching interventions for vulnerable and underserved populations – since often they bear the greatest burden of disease – should be a priority. These types of studies may require interdisciplinary teams (public health experts, sociologists, economists) and can be complex, but their outcomes could influence policy and allocation of resources in ways that yield large public health gains. The Lancet advocated a “common risk factor” approach – where oral health is improved not in isolation, but as part of broader efforts to curb sugar, tobacco, etc., alongside other NCDs. Research that demonstrates the oral health benefits of, say, a sugar tax or a smoking cessation program in dental settings could bolster arguments for those measures.
8. Rapid Dissemination and Implementation: Once good evidence is generated, there should be systems to disseminate it quickly. Dental journals can provide clinician summaries; organizations can send out alerts or updates when a practice-changing study comes out (similar to how the CDC might issue new recommendations following a big trial). Implementation science – studying how to effectively get providers to adopt new practices – should be applied in dentistry. For example, if a new guideline says “use X for caries arrest,” researchers could test strategies like reminder systems, audit and feedback, or financial incentives to see how to get clinics to actually do it. As noted earlier, bridging that last mile from evidence to routine practice often needs its own research and resources.
In concluding the strategies, it’s important to keep patients at the center. Every research project or guideline should ask: how will this ultimately benefit patients? Involve patients in setting research priorities (the “patient-centered outcomes research” movement is making inroads, even in dentistry, by including patient representatives on panels deciding what to study or what outcomes matter). Engaging the public can also increase support for oral health research funding if people recognize it can improve their well-being and not just their teeth in isolation.
Conclusion
Dentistry stands at a crossroad between its artisanal past and a more scientific future. The weaknesses in dental research – from methodological flaws and small trials to disciplinary isolation and slow evidence uptake – have constrained our ability to fully serve our patients with the best that science can offer. The result has been a profession often guided by habit and intuition, and a global population still suffering extensively from largely preventable oral diseases. However, this analysis also highlights reason for optimism. Awareness of these shortcomings is the first step toward addressing them, and indeed, the dental research community has begun to implement changes: improving research quality, forging interdisciplinary links, developing standardized outcomes, and focusing on evidence-based practice reform.
The stakes are high. Oral health is integral to general health, comfort, and dignity. Virtually every person is affected by oral disease at some point – be it the child with tooth decay, the adult with periodontal disease, or the elder who has lost teeth. These conditions collectively affect billions and impose enormous social and economic burdens. Yet, unlike many medical conditions, we largely know how to prevent and manage these diseases; what’s lacking is the robust evidence and implementation systems to ensure that knowledge is applied universally and effectively. Strengthening dental research is not an academic exercise, but a practical necessity to close the gap between what is and what could be in oral health care.
By investing in high-quality, relevant research and by embracing a culture that rapidly translates findings into practice, dentistry can overcome its evidence weaknesses. Future dental clinicians should be as comfortable reading a forest plot from a meta-analysis as they are holding a handpiece, and future dental patients should be able to trust that the advice and treatments they receive are grounded in solid proof. With a more rigorous foundation, we can standardize care on effective practices, reduce unwarranted variation, and phase out interventions that don’t truly help. In turn, patient outcomes will improve – fewer cavities, teeth kept for a lifetime, better quality of life, and even contributions to better overall health.
The path forward will require collective effort: researchers must prioritize collaboration and rigor; educators must train evidence-conscious practitioners; clinicians must be open to continual learning and change; and policymakers must integrate oral health into broader health initiatives and funding. Breaking down the historical silos – between research and practice, and between dentistry and medicine – will yield innovations and efficiencies that benefit all. As one commentary put it, it’s time for oral health to “come off the bench” and join the frontlines of healthcare.
In summary, the challenges in dental research are significant but not insurmountable. By recognizing and addressing the weaknesses detailed in this article, the dental profession can enhance the strength and credibility of its evidence base. This will underpin a more scientific, effective, and unified approach to care – one where best practices are not suggestions 20 years late, but realities in every dental office. The result will be better health for the patients and communities we serve, fulfilling the ultimate promise of both dentistry and research: to improve lives through knowledge.
Sources
- van der Wouden P, et al. BDJ Open. 2022 – Analysis showing 85.5% of references in dental journals are to other dental journals, indicating siloing and drift toward basic science.
- Randall CL, et al. Community Dent Oral Epidemiol. 2023 – Discussion on evidence-to-practice gap averaging 17 years, with dentistry lagging behind other fields in implementation.
- Hinton S, et al. J Long Term Eff Med Implants. 2015 – Found many dental RCTs had unclear/high risk of bias, highlighting poor reporting quality in half of studies.
- Saltaji H, et al. J Evid Based Dent Pract. 2021 – Meta-epidemiological study showing trials with high/unclear sponsorship bias reported significantly larger effect sizes; 83% of trials had unclear or high risk of sponsorship bias.
- Popelut A, et al. PLOS ONE. 2010 – Found industry-funded implant studies reported much lower failure rates than non-industry studies, suggesting significant sponsorship bias in outcomes.
- Watt RG, et al. Lancet. 2019 – Critique of dentistry in high-income countries for not addressing disease causes; highlights influence of sugar industry on dental research and policy.
- Nguyen TM, et al. J Dent Res. 2024 – Commentary noting DMFT index limitations: does not indicate disease severity or impact on quality of life, and that DALYs/QALYs are not well used in oral health.
- Bader JD & Shugars DA. J Public Health Dent. 1995 – Review confirming substantial variation in dentists’ clinical decisions even when patient factors are controlled.
- Slawson N. The Guardian. 2016 – Reporting on AP investigation: evidence for flossing is “weak, very unreliable,” leading to guidelines dropping the floss recommendation.
- Ghanbarzadegan A, et al. Aust Dent J. 2023 – Found oral health has the lowest research funding relative to disease burden in Australia; only $15M (0.23%) of major grants went to oral disorders (2017–21).
- ADA News. 2019 – Survey: only 47% of general dentists always use rubber dam for root canals, indicating slow uptake of evidence-based standard.
- IADR Implant Dentistry Core Outcomes. 2020 – Consensus established mandatory core outcomes for implant trials to improve consistency.
- Lancet Oral Health Series (Editorial). 2019 – Calls for integrating dentistry into primary care and tackling common risk factors (sugar, tobacco) through policy, reflecting need for broader engagement.
- Kassebaum NJ, et al. J Dent Res. 2017 – Global Burden of Disease study: 3.5 billion people with oral conditions in 2015; untreated caries is the most prevalent condition worldwide.
-
Kearns CE & Bero L. Lancet. 2019 – Commentary on conflicts of interest: dental research organizations have not focused on sugars for years, needing reform in COI policies.